Background Human T-cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus that
causes a lifelong infection. Several diseases, including an aggressive form of leukaemia …

HTLV-1 is a retrovirus that causes lifelong T-cell infection in humans, impacting the host
immune response. This virus causes a range of clinical manifestations, from inflammatory …

It is 30 years since human T-cell leukemia virus type 1 (HTLV-1) was identified as the first
human retrovirus. To assess the implications of the virus for human health it is very important …

ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …

The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …

Human T-lymphotropic virus type I (HTLV-I) causes HTLV-I-associated myelopathy/tropical
spastic paraparesis and adult T cell leukemia in a small percentage of infected individuals …

Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

The human T-lymphotropic virus type 1 (HTLV-1, also known as the human T-cell leukaemia
virus type 1) has been shown to cause severe disease in some people infected with the …

Objective: Hospital and laboratory data indicate that human T‐lymphotropic virus type 1
(HTLV‐1) is endemic to central Australia, but no community‐based studies of its prevalence …